Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Daan Crommelin
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Concepts & Ideas
Physiology
Devices
Anatomy
Procedures
Objects
Sign-in to see full Profile
Network (preview)
64
Hennink, Wim
48
Jiskoot, Wim
37
Storm, Gert
15
Kersten, Gideon
13
Talsma, Herre
11
Mastrobattista, Enrico
10
van Nostrum, Cornelus
10
Verrijk, Ruud
10
Eling, Wijnand
9
Zuidam, NJ
8
Koning, Gerben
8
van Steenbergen, Mies
8
Steerenberg, Peter
7
Boerman, Otto
7
Cherng, JY
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Daan Crommelin (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: van Hell Albert J; Crommelin Daan J A; Hennink Wim E; Mastrobattista Enrico
Stabilization of peptide vesicles by introducing inter-peptide disulfide bonds.
Pharmaceutical research 2009;26(9):2186-93.
-
2009: Carpenter John F; Randolph Theodore W; Jiskoot Wim; Crommelin Daan J A; Middaugh C Russell; Winter Gerhard; Fan Ying-Xin; Kirshner Susan; Verthelyi Daniela; Kozlowski Steven; Clouse Kathleen A; Swann Patrick G; Rosenberg Amy; Cherney Barry
Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality.
Journal of pharmaceutical sciences 2009;98(4):1201-5.
-
2008: Bouchard Andréanne; Jovanovic Natasa; de Boer Anne H; Martín Angel; Jiskoot Wim; Crommelin Daan J A; Hofland Gerard W; Witkamp Geert-Jan
Effect of the spraying conditions and nozzle design on the shape and size distribution of particles obtained with supercritical fluid drying.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;70(1):389-401.
-
2008: Amidi Maryam; Krudys Kevin M; Snel Cor J; Crommelin Daan J A; Della Pasqua Oscar E; Hennink Wim E; Jiskoot Wim
Efficacy of pulmonary insulin delivery in diabetic rats: use of a model-based approach in the evaluation of insulin powder formulations.
Journal of controlled release : official journal of the Controlled Release Society 2008;127(3):257-66.
-
2008: Carstens Myrra G; de Jong Pascal H J L F; van Nostrum Cornelus F; Kemmink Johan; Verrijk Ruud; de Leede Leo G J; Crommelin Daan J A; Hennink Wim E
The effect of core composition in biodegradable oligomeric micelles as taxane formulations.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;68(3):596-606.
-
2008: Bouchard Andréanne; Jovanovic Natasa; Hofland Gerard W; Jiskoot Wim; Mendes Eduardo; Crommelin Daan J A; Witkamp Geert-Jan
Supercritical fluid drying of carbohydrates: selection of suitable excipients and process conditions.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;68(3):781-94.
-
2008: Amidi Maryam; Pellikaan Hubert C; de Boer Anne H; Crommelin Daan J A; Hennink Wim E; Jiskoot Wim
Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;68(2):191-200.
-
2008: Jovanovic Natasa; Bouchard Andréanne; Hofland Gerard W; Witkamp Geert-Jan; Crommelin Daan J A; Jiskoot Wim
Stabilization of IgG by supercritical fluid drying: optimization of formulation and process parameters.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;68(2):183-90.
-
2008: Carstens Myrra G; van Nostrum Cornelus F; Verrijk Ruud; de Leede Leo G J; Crommelin Daan J A; Hennink Wim E
A mechanistic study on the chemical and enzymatic degradation of PEG-Oligo(epsilon-caprolactone) micelles.
Journal of pharmaceutical sciences 2008;97(1):506-18.
-
2008: Jovanovic Natasa; Bouchard Andréanne; Sutter Marc; Van Speybroeck Michiel; Hofland Gerard W; Witkamp Geert-Jan; Crommelin Daan J A; Jiskoot Wim
Stable sugar-based protein formulations by supercritical fluid drying.
International journal of pharmaceutics 2008;346(1-2):102-8.
-
2007: Vlugt-Wensink K D F; de Vrueh R; Gresnigt M G; Hoogerbrugge C M; van Buul-Offers S C; de Leede L G J; Sterkman L G W; Crommelin D J A; Hennink W E; Verrijk R
Preclinical and clinical in vitro in vivo correlation of an hGH dextran microsphere formulation.
Pharmaceutical research 2007;24(12):2239-48.
-
2007: Vlugt-Wensink K D F; Meijer Y J; van Steenbergen M J; Verrijk R; Jiskoot W; Crommelin D J A; Hennink W E
Effect of excipients on the encapsulation efficiency and release of human growth hormone from dextran microspheres.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2007;67(3):589-96.
-
2007: Metz Bernard; Jiskoot Wim; Mekkes Dirk; Kingma Robert; Hennink Wim E; Crommelin Daan J A; Kersten Gideon F A
Quality control of routine, experimental and real-time aged diphtheria toxoids by in vitro analytical techniques.
Vaccine 2007;25(39-40):6863-71.
-
2007: van Hell Albert J; Costa Cristina I C A; Flesch Frits M; Sutter Marc; Jiskoot Wim; Crommelin Daan J A; Hennink Wim E; Mastrobattista Enrico
Self-assembly of recombinant amphiphilic oligopeptides into vesicles.
Biomacromolecules 2007;8(9):2753-61.
-
2007: Amidi Maryam; Pellikaan Hubert C; Hirschberg Hoang; de Boer Anne H; Crommelin Daan J A; Hennink Wim E; Kersten Gideon; Jiskoot Wim
Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs.
Vaccine 2007;25(37-38):6818-29.
-
2007: van der Aa M A E M; Huth U S; Häfele S Y; Schubert R; Oosting R S; Mastrobattista E; Hennink W E; Peschka-Süss R; Koning G A; Crommelin D J A
Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells.
Pharmaceutical research 2007;24(8):1590-8.
-
2007: Amidi Maryam; Romeijn Stefan G; Verhoef J Coos; Junginger Hans E; Bungener Laura; Huckriede Anke; Crommelin Daan J A; Jiskoot Wim
N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
Vaccine 2007;25(1):144-53.
-
2006: Carstens M G; van Nostrum C F; Ramzi A; de Leede L G J; Crommelin D J A; Hennink W E
Self-assembly of PEG-oligolactates with monodisperse hydrophobic blocks.
Journal of controlled release : official journal of the Controlled Release Society 2006;116(2):e40-1.
-
2006: Vlugt-Wensink Karin D F; Jiang Xulin; Schotman Geert; Kruijtzer Govert; Vredenberg Arjen; Chung Jin T; Zhang Zhibing; Versluis Cees; Ramos Delphine; Verrijk Ruud; Jiskoot Wim; Crommelin Daan J A; Hennink Wim E
In vitro degradation behavior of microspheres based on cross-linked dextran.
Biomacromolecules 2006;7(11):2983-90.
-
2006: van Gaal Ethlinn V B; Hennink Wim E; Crommelin Daan J A; Mastrobattista Enrico
Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy.
Pharmaceutical research 2006;23(6):1053-74.
-
2006: Metz Bernard; Kersten Gideon F A; Baart Gino J E; de Jong Ad; Meiring Hugo; ten Hove Jan; van Steenbergen Mies J; Hennink Wim E; Crommelin Daan J A; Jiskoot Wim
Identification of formaldehyde-induced modifications in proteins: reactions with insulin.
Bioconjugate chemistry 2006;17(3):815-22.
-
2006: Hermeling Suzanne; Schellekens Huub; Maas Coen; Gebbink Martijn F B G; Crommelin Daan J A; Jiskoot Wim
Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation.
Journal of pharmaceutical sciences 2006;95(5):1084-96.
-
2006: van der Aa Marieke A E M; Mastrobattista Enrico; Oosting Ronald S; Hennink Wim E; Koning Gerben A; Crommelin Daan J A
The nuclear pore complex: the gateway to successful nonviral gene delivery.
Pharmaceutical research 2006;23(3):447-59.
-
2006: Hermeling Suzanne; Jiskoot Wim; Crommelin Daan J A; Schellekens Huub
Reaction to the paper: interaction of polysorbate 80 with erythropoietin: a case study in protein-surfactant interactions.
Pharmaceutical research 2006;23(3):641-2; author reply 643-4.
-
2006: Vlugt-Wensink Karin D F; Vlugt Thijs J H; Jiskoot Wim; Crommelin Daan J A; Verrijk Ruud; Hennink Wim E
Modeling the release of proteins from degrading crosslinked dextran microspheres using kinetic Monte Carlo simulations.
Journal of controlled release : official journal of the Controlled Release Society 2006;111(1-2):117-27.
-
2006: Jovanovic Natasa; Bouchard Andréanne; Hofland Gerard W; Witkamp Geert-Jan; Crommelin Daan J A; Jiskoot Wim
Distinct effects of sucrose and trehalose on protein stability during supercritical fluid drying and freeze-drying.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2006;27(4):336-45.
-
2006: Mastrobattista Enrico; van der Aa Marieke A E M; Hennink Wim E; Crommelin Daan J A
Artificial viruses: a nanotechnological approach to gene delivery.
Nature reviews. Drug discovery 2006;5(2):115-21.
-
2005: Hermeling Suzanne; Aranha Liliana; Damen J Mirjam A; Slijper Monique; Schellekens Huub; Crommelin Daan J A; Jiskoot Wim
Structural characterization and immunogenicity in wild-type and immune tolerant mice of degraded recombinant human interferon alpha2b.
Pharmaceutical research 2005;22(12):1997-2006.
-
2005: Carstens Myrra G; van Nostrum Cornelus F; Ramzi Aissa; Meeldijk Johannes D; Verrijk Ruud; de Leede Leo L; Crommelin Daan J A; Hennink Wim E
Poly(ethylene glycol)--oligolactates with monodisperse hydrophobic blocks: preparation, characterization, and behavior in water.
Langmuir : the ACS journal of surfaces and colloids 2005;21(24):11446-54.
-
2005: Zhao Yixian; Benita Yair; Lok Martin; Kuipers Betsy; van der Ley Peter; Jiskoot Wim; Hennink Wim E; Crommelin Daan J A; Oosting Ronald S
Multi-antigen immunization using IgG binding domain ZZ as carrier.
Vaccine 2005;23(43):5082-90.
-
2005: Arigita Carmen; Luijkx Thomas; Jiskoot Wim; Poelen Martien; Hennink Wim E; Crommelin Daan J A; Ley Peter van der; Els Cecile van; Kersten Gideon F A
Well-defined and potent liposomal meningococcal B vaccines adjuvated with LPS derivatives.
Vaccine 2005;23(43):5091-8.
-
2005: Hermeling Suzanne; Jiskoot Wim; Crommelin Daan; Bornaes Claus; Schellekens Huub
Development of a transgenic mouse model immune tolerant for human interferon Beta.
Pharmaceutical research 2005;22(6):847-51.
-
2005: Visser Corine C; Stevanovic Sanja; Voorwinden L Heleen; van Bloois Louis; Gaillard Pieter J; Danhof Meindert; Crommelin Daan J A; de Boer Albertus G
Targeting liposomes with protein drugs to the blood-brain barrier in vitro.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2005;25(2-3):299-305.
-
2005: Couvreur Patrick; Barguer Diane; Crommelin Daan J A; Duchêne Dominique; Engels Joachim W; Kerr David J; Krogsgaard-Larsen Povl; Meijer Dirk K; Paoletti Rodolfo; Wagner Ernst;
EUFEPS report. Contribution of academic research to discovery and development of medicines: current status and future opportunities.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2005;24(2-3):245-52.
-
2005: Funhoff Arjen M; Monge Sophie; Teeuwen Rosalie; Koning Gerben A; Schuurmans-Nieuwenbroek Nancy M E; Crommelin Daan J A; Haddleton David M; Hennink Wim E; van Nostrum Cornelus F
PEG shielded polymeric double-layered micelles for gene delivery.
Journal of controlled release : official journal of the Controlled Release Society 2005;102(3):711-24.
-
2005: van der Aa M A E M; Koning G A; d'Oliveira C; Oosting R S; Wilschut K J; Hennink W E; Crommelin D J A
An NLS peptide covalently linked to linear DNA does not enhance transfection efficiency of cationic polymer based gene delivery systems.
The journal of gene medicine 2005;7(2):208-17.
-
2005: van der Aa M; Koning G; van der Gugten J; d'Oliveira C; Oosting R; Hennink W E; Crommelin D J A
Covalent attachment of an NLS-peptide to linear dna does not enhance transfection efficiency of cationic polymer based gene delivery systems.
Journal of controlled release : official journal of the Controlled Release Society 2005;101(1-3):395-7.
-
2005: Funhoff Arjen M; van Nostrum Cornelus F; Lok Martin C; Kruijtzer John A W; Crommelin Daan J A; Hennink Wim E
Cationic polymethacrylates with covalently linked membrane destabilizing peptides as gene delivery vectors.
Journal of controlled release : official journal of the Controlled Release Society 2005;101(1-3):233-46.
-
2005: Crommelin Daan; Bermejo Theresa; Bissig Marco; Damiaans Jaak; Krämer Irene; Rambourg Patrick; Scroccaro Giovanna; Strukelj Borut; Tredree Roger; Ronco Claudio
Biosimilars, generic versions of the first generation of therapeutic proteins: do they exist?
Contributions to nephrology 2005;149():287-94.
-
2004: Bos Gert W; Kanellos Theofanis; Crommelin Daan J A; Hennink Wim E; Howard Colin R
Cationic polymers that enhance the performance of HbsAg DNA in vivo.
Vaccine 2004;23(4):460-9.
-
2004: Crommelin Daan J A
Delivery of biologicals: the wish list is long...
Expert opinion on drug delivery 2004;1(1):3-5.
-
2004: Jovanovic Natasa; Bouchard Andréanne; Hofland Gerard W; Witkamp Geert-Jan; Crommelin Daan J A; Jiskoot Wim
Stabilization of proteins in dry powder formulations using supercritical fluid technology.
Pharmaceutical research 2004;21(11):1955-69.
-
2004: Funhoff Arjen M; van Nostrum Cornelus F; Lok Martin C; Fretz Marjan M; Crommelin Daan J A; Hennink Wim E
Poly(3-guanidinopropyl methacrylate): a novel cationic polymer for gene delivery.
Bioconjugate chemistry 2004;15(6):1212-20.
-
2004: Homhuan Atthachai; Prakongpan Sompol; Poomvises Prachak; Maas Riks A; Crommelin Daan J A; Kersten Gideon F A; Jiskoot Wim
Virosome and ISCOM vaccines against Newcastle disease: preparation, characterization and immunogenicity.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2004;22(5):459-68.
-
2004: Hermeling Suzanne; Crommelin Daan J A; Schellekens Huub; Jiskoot Wim
Structure-immunogenicity relationships of therapeutic proteins.
Pharmaceutical research 2004;21(6):897-903.
-
2004: Visser Corine C; Voorwinden L Heleen; Crommelin Daan J A; Danhof Meindert; de Boer Albertus G
Characterization and modulation of the transferrin receptor on brain capillary endothelial cells.
Pharmaceutical research 2004;21(5):761-9.
-
2004: Visser Corine C; Stevanovic Sanja; Heleen Voorwinden L; Gaillard Pieter J; Crommelin Daan J A; Danhof Meindert; De Boer Albertus G
Validation of the transferrin receptor for drug targeting to brain capillary endothelial cells in vitro.
Journal of drug targeting 2004;12(3):145-50.
-
2004: Burgess Diane J; Crommelin Daan J A; Hussain Ajaz S; Chen Mei-Ling
Assuring quality and performance of sustained and controlled released parenterals.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2004;21(5):679-90.
-
2004: Burgess Diane J; Crommelin Daan J A; Hussain Ajaz S; Chen Mei-Ling;
Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop report.
AAPS pharmSci 2004;6(1):E11.
-
2004: Arigita Carmen; van den Berg Joost; Wensink Karin; van Steenbergen Mies; Hennink Wim E; Crommelin Daan J A; Kersten Gideon F A; Jiskoot Wim
Immunogenicity of meningococcal PorA formulations encapsulated in biodegradable microspheres.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2004;21(2-3):131-41.
-
2004: Metz Bernard; Kersten Gideon F A; Hoogerhout Peter; Brugghe Humphrey F; Timmermans Hans A M; de Jong Ad; Meiring Hugo; ten Hove Jan; Hennink Wim E; Crommelin Daan J A; Jiskoot Wim
Identification of formaldehyde-induced modifications in proteins: reactions with model peptides.
The Journal of biological chemistry 2004;279(8):6235-43.
-
2004: Funhoff Arjen M; van Nostrum Cornelus F; Janssen Adriënne P C A; Fens Marcel H A M; Crommelin Daan J A; Hennink Wim E
Polymer side-chain degradation as a tool to control the destabilization of polyplexes.
Pharmaceutical research 2004;21(1):170-6.
-
2004: Arigita Carmen; Jiskoot Wim; Westdijk Janny; van Ingen Cor; Hennink Wim E; Crommelin Daan J A; Kersten Gideon F A
Stability of mono- and trivalent meningococcal outer membrane vesicle vaccines.
Vaccine 2004;22(5-6):629-42.
-
2004: Verbaan F J; Oussoren C; Snel C J; Crommelin D J A; Hennink W E; Storm G
Steric stabilization of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes mediates prolonged circulation and tumor targeting in mice.
The journal of gene medicine 2004;6(1):64-75.
-
2004: Funhoff Arjen M; van Nostrum Cornelus F; Koning Gerben A; Schuurmans-Nieuwenbroek Nancy M E; Crommelin Daan J A; Hennink Wim E
Endosomal escape of polymeric gene delivery complexes is not always enhanced by polymers buffering at low pH.
Biomacromolecules 2004;5(1):32-9.
-
2004: Burgess Diane J; Crommelin Daan J A; Hussain Ajaz S; Chen Mei-Ling
Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop report.
The AAPS journal 2004;6(1):100-11.
-
2004: Visser Corine C; Voorwinden L Heleen; Harders Liesbeth R; Eloualid Mohamed; van Bloois Louis; Crommelin Daan J A; Danhof Meindert; de Boer Albertus G
Coupling of metal containing homing devices to liposomes via a maleimide linker: use of TCEP to stabilize thiol-groups without scavenging metals.
Journal of drug targeting 2004;12(9-10):569-73.
-
2003: Hermeling Suzanne; Schellekens Huub; Crommelin Daan J A; Jiskoot Wim
Micelle-associated protein in epoetin formulations: aA risk factor for immunogenicity?
Pharmaceutical research 2003;20(12):1903-7.
-
2003: Metz Bernard; Jiskoot Wim; Hennink Wim E; Crommelin Daan J A; Kersten Gideon F A
Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines.
Vaccine 2003;22(2):156-67.
-
2003: Metselaar Josbert M; Bruin Peter; de Boer Leo W T; de Vringer Tom; Snel Cor; Oussoren Christien; Wauben Marca H M; Crommelin Daan J A; Storm Gert; Hennink Wim E
A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity.
Bioconjugate chemistry 2003;14(6):1156-64.
-
2003: Schellekens Huub; Crommelin Daan J A
Equivocal role of micelles in Eprex adverse events.
Nature biotechnology 2003;21(11):1265; author reply 1266.
-
2003: Crommelin Daan J A; Storm Gert; Verrijk Ruud; de Leede Leo; Jiskoot Wim; Hennink Wim E
Shifting paradigms: biopharmaceuticals versus low molecular weight drugs.
International journal of pharmaceutics 2003;266(1-2):3-16.
-
2003: Arigita Carmen; Bevaart Lisette; Everse Linda A; Koning Gerben A; Hennink Wim E; Crommelin Daan J A; van de Winkel Jan G J; van Vugt Martine J; Kersten Gideon F A; Jiskoot Wim
Liposomal meningococcal B vaccination: role of dendritic cell targeting in the development of a protective immune response.
Infection and immunity 2003;71(9):5210-8.
-
2003: Luten J; van Steenis J H; van Someren R; Kemmink J; Schuurmans-Nieuwenbroek N M E; Koning G A; Crommelin D J A; van Nostrum C F; Hennink W E
Water-soluble biodegradable cationic polyphosphazenes for gene delivery.
Journal of controlled release : official journal of the Controlled Release Society 2003;89(3):483-97.
-
2003: Crommelin Daan J A; Storm Gert
Liposomes: from the bench to the bed.
Journal of liposome research 2003;13(1):33-6.
-
2003: van Steenis J H; van Maarseveen E M; Verbaan F J; Verrijk R; Crommelin D J A; Storm G; Hennink W E
Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes.
Journal of controlled release : official journal of the Controlled Release Society 2003;87(1-3):167-76.
-
2003: Crommelin Daan J A; Storm Gert; Jiskoot Wim; Stenekes Robert; Mastrobattista Enrico; Hennink Wim E
Nanotechnological approaches for the delivery of macromolecules.
Journal of controlled release : official journal of the Controlled Release Society 2003;87(1-3):81-8.
-
2003: Arigita Carmen; Kersten Gideon F A; Hazendonk Ton; Hennink Wim E; Crommelin Daan J A; Jiskoot Wim
Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes.
Vaccine 2003;21(9-10):950-60.
-
2003: Kersten Gideon F A; Crommelin Daan J A
Liposomes and ISCOMs.
Vaccine 2003;21(9-10):915-20.
-
2002: Luisa Corvo M; Jorge João C S; van't Hof Ron; Cruz M Eugénia M; Crommelin Daan J A; Storm Gert
Superoxide dismutase entrapped in long-circulating liposomes: formulation design and therapeutic activity in rat adjuvant arthritis.
Biochimica et biophysica acta 2002;1564(1):227-36.
-
2002: van de Weert Marco; van Dijkhuizen-Radersma Riemke; Bezemer Jeroen M; Hennink Wim E; Crommelin Daan J A
Reversible aggregation of lysozyme in a biodegradable amphiphilic multiblock copolymer.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2002;54(1):89-93.
-
2002: van de Weert Marco; van Steenbergen Marinus J; Cleland Jeffrey L; Heller Jorge; Hennink Wim E; Crommelin Daan J A
Semisolid, self-catalyzed poly(ortho ester)s as controlled-release systems: protein release and protein stability issues.
Journal of pharmaceutical sciences 2002;91(4):1065-74.
-
2002: Mastrobattista Enrico; Crommelin Daan J A; Wilschut Jan; Storm Gert
Targeted liposomes for delivery of protein-based drugs into the cytoplasm of tumor cells.
Journal of liposome research 2002;12(1-2):57-65.
-
2002: Vernooij E A A M; Kettenes-van den Bosch J J; Underberg W J M; Crommelin D J A
Chemical hydrolysis of DOTAP and DOPE in a liposomal environment.
Journal of controlled release : official journal of the Controlled Release Society 2002;79(1-3):299-303.
-
2001: Mastrobattista E; Schoen P; Wilschut J; Crommelin D J; Storm G
Targeting influenza virosomes to ovarian carcinoma cells.
FEBS letters 2001;509(1):71-6.
-
2001: van de Weert M; Haris P I; Hennink W E; Crommelin D J
Fourier transform infrared spectrometric analysis of protein conformation: effect of sampling method and stress factors.
Analytical biochemistry 2001;297(2):160-9.
-
2001: Mastrobattista E; Kapel R H; Eggenhuisen M H; Roholl P J; Crommelin D J; Hennink W E; Storm G
Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells.
Cancer gene therapy 2001;8(6):405-13.
-
2001: Mollee H M; Steenvoorden D P; De Vringer T; Crommelin D J
The influence of the incorporation of cholesterol and water on the particle size, bilayer thickness, melting behavior, and relative sucrose ester composition of reversed vesicles.
Journal of pharmaceutical sciences 2001;90(5):588-98.
-
2001: Verbaan F J; Oussoren C; van Dam I M; Takakura Y; Hashida M; Crommelin D J; Hennink W E; Storm G
The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration.
International journal of pharmaceutics 2001;214(1-2):99-101.
-
2001: Stenekes R J; Loebis A E; Fernandes C M; Crommelin D J; Hennink W E
Degradable dextran microspheres for the controlled release of liposomes.
International journal of pharmaceutics 2001;214(1-2):17-20.
-
2001: Van Slooten M L; Boerman O; Romøren K; Kedar E; Crommelin D J; Storm G
Liposomes as sustained release system for human interferon-gamma: biopharmaceutical aspects.
Biochimica et biophysica acta 2001;1530(2-3):134-45.
-
2000: Bos G W; Trullas-Jimeno A; Jiskoot W; Crommelin D J; Hennink W E
Sterilization of poly(dimethylamino) ethyl methacrylate-based gene transfer complexes.
International journal of pharmaceutics 2000;211(1-2):79-88.
-
2000: van Slooten M L; Visser A J; van Hoek A; Storm G; Crommelin D J; Jiskoot W
Conformational stability of human interferon-gamma on association with and dissociation from liposomes.
Journal of pharmaceutical sciences 2000;89(12):1605-19.
-
2000: van de Weert M; Hoechstetter J; Hennink W E; Crommelin D J
The effect of a water/organic solvent interface on the structural stability of lysozyme.
Journal of controlled release : official journal of the Controlled Release Society 2000;68(3):351-9.
-
2000: van de Weert M; van 't Hof1 R; van der Weerd J; Heeren R M; Posthuma G; Hennink W E; Crommelin D J
Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques.
Journal of controlled release : official journal of the Controlled Release Society 2000;68(1):31-40.
-
2000: van Rensen A J; Taams L S; Grosfeld-Stulemeyer M C; van Eden W; Crommelin D J; Wauben M H
Induction of T cell anergy by liposomes with incorporated major histocompatibility complex (MHC) II/peptide complexes.
Pharmaceutical research 2000;17(6):720-6.
-
2000: Stenekes R J; Loebis A E; Fernandes C M; Crommelin D J; Hennink W E
Controlled release of liposomes from biodegradable dextran microspheres: a novel delivery concept.
Pharmaceutical research 2000;17(6):690-5.
-
2000: Corvo M L; Boerman O C; Oyen W J; Jorge J C; Cruz M E; Crommelin D J; Storm G
Subcutaneous administration of superoxide dismutase entrapped in long circulating liposomes: in vivo fate and therapeutic activity in an inflammation model.
Pharmaceutical research 2000;17(5):600-6.
-
2000: van de Wetering P; Schuurmans-Nieuwenbroek N M; van Steenbergen M J; Crommelin D J; Hennink W E
Copolymers of 2-(dimethylamino)ethyl methacrylate with ethoxytriethylene glycol methacrylate or N-vinyl-pyrrolidone as gene transfer agents.
Journal of controlled release : official journal of the Controlled Release Society 2000;64(1-3):193-203.
-
2000: van Slooten M L; Storm G; Zoephel A; Küpcü Z; Boerman O; Crommelin D J; Wagner E; Kircheis R
Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines.
Pharmaceutical research 2000;17(1):42-8.
-
2000: Zuidam N J; Posthuma G; de Vries E T; Crommelin D J; Hennink W E; Storm G
Effects of physicochemical characteristics of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes on cellular association and internalization.
Journal of drug targeting 2000;8(1):51-66.
-
1999: Crommelin D J; van Rensen A J; Wauben M H; Storm G
Liposomes in autoimmune diseases: selected applications in immunotherapy and inflammation detection.
Journal of controlled release : official journal of the Controlled Release Society 1999;62(1-2):245-51.
-
1999: Vernooij E A; Gentry C A; Herron J N; Crommelin D J; Kettenes-van den Bosch J J
1H NMR quantification of poly(ethylene glycol)-phosphatidylethanolamine in phospholipid mixtures.
Pharmaceutical research 1999;16(10):1658-61.
-
1999: Arigita C; Zuidam N J; Crommelin D J; Hennink W E
Association and dissociation characteristics of polymer/DNA complexes used for gene delivery.
Pharmaceutical research 1999;16(10):1534-41.
-
1999: Cherng J Y; Talsma H; Crommelin D J; Hennink W E
Long term stability of poly((2-dimethylamino)ethyl methacrylate)-based gene delivery systems.
Pharmaceutical research 1999;16(9):1417-23.
-
1999: Cherng J Y; Schuurmans-Nieuwenbroek N M; Jiskoot W; Talsma H; Zuidam N J; Hennink W E; Crommelin D J
Effect of DNA topology on the transfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid complexes.
Journal of controlled release : official journal of the Controlled Release Society 1999;60(2-3):343-53.
-
1999: van Dijk-Wolthuis W N; van de Wetering P; Hinrichs W L; Hofmeyer L J; Liskamp R M; Crommelin D J; Hennink W E
A versatile method for the conjugation of proteins and peptides to poly[2-(dimethylamino)ethyl methacrylate].
Bioconjugate chemistry 1999;10(4):687-92.
-
1999: Mastrobattista E; Storm G; van Bloois L; Reszka R; Bloemen P G; Crommelin D J; Henricks P A
Cellular uptake of liposomes targeted to intercellular adhesion molecule-1 (ICAM-1) on bronchial epithelial cells.
Biochimica et biophysica acta 1999;1419(2):353-63.
-
1999: Corvo M L; Boerman O C; Oyen W J; Van Bloois L; Cruz M E; Crommelin D J; Storm G
Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis.
Biochimica et biophysica acta 1999;1419(2):325-34.
-
1999: Stenekes R J; Franssen O; van Bommel E M; Crommelin D J; Hennink W E
The use of aqueous PEG/dextran phase separation for the preparation of dextran microspheres.
International journal of pharmaceutics 1999;183(1):29-32.
-
1999: Cherng J Y; vd Wetering P; Talsma H; Crommelin D J; Hennink W E
Stabilization of polymer-based gene delivery systems.
International journal of pharmaceutics 1999;183(1):25-8.
-
1999: Cherng J Y; Talsma H; Verrijk R; Crommelin D J; Hennink W E
The effect of formulation parameters on the size of poly-((2-dimethylamino)ethyl methacrylate)-plasmid complexes.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 1999;47(3):215-24.
-
1999: Postma N S; Hermsen R C; Crommelin D J; Eling W M; Zuidema J
Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice.
Antimicrobial agents and chemotherapy 1999;43(5):1027-33.
-
1999: van Winden E C; Crommelin D J
Short term stability of freeze-dried, lyoprotected liposomes.
Journal of controlled release : official journal of the Controlled Release Society 1999;58(1):69-86.
-
1999: van Rensen A J; Wauben M H; Grosfeld-Stulemeyer M C; van Eden W; Crommelin D J
Liposomes with incorporated MHC class II/peptide complexes as antigen presenting vesicles for specific T cell activation.
Pharmaceutical research 1999;16(2):198-204.
-
1999: Postma N S; Hermsen C C; Crommelin D J; Zuidema J; Eling W M
Treatment with recombinant human tumour necrosis factor-alpha reduces parasitaemia and prevents Plasmodium berghei K173-induced experimental cerebral malaria in mice.
Parasitology 1999;118 ( Pt 1)():7-15.
-
1999: Postma N S; Crommelin D J; Eling W M; Zuidema J
Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice.
The Journal of pharmacology and experimental therapeutics 1999;288(1):114-20.
-
1998: Koppenhagen F J; Küpcü Z; Wallner G; Crommelin D J; Wagner E; Storm G; Kircheis R
Sustained cytokine delivery for anticancer vaccination: liposomes as alternative for gene-transfected tumor cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(8):1881-6.
-
1998: Koppenhagen F J; Visser A J; Herron J N; Storm G; Crommelin D J
Interaction of recombinant interleukin-2 with liposomal bilayers.
Journal of pharmaceutical sciences 1998;87(6):707-14.
-
1998: van de Wetering P; Cherng J Y; Talsma H; Crommelin D J; Hennink W E
2-(Dimethylamino)ethyl methacrylate based (co)polymers as gene transfer agents.
Journal of controlled release : official journal of the Controlled Release Society 1998;53(1-3):145-53.
-
1998: Stenekes R J; Franssen O; van Bommel E M; Crommelin D J; Hennink W E
The preparation of dextran microspheres in an all-aqueous system: effect of the formulation parameters on particle characteristics.
Pharmaceutical research 1998;15(4):557-61.
-
1998: Oussoren C; Eling W M; Crommelin D J; Storm G; Zuidema J
The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue against local toxicity of two antitumor drugs.
Biochimica et biophysica acta 1998;1369(1):159-72.
-
1998: van Winden E C; Talsma H; Crommelin D J
Thermal analysis of freeze-dried liposome-carbohydrate mixtures with modulated temperature differential scanning calorimetry.
Journal of pharmaceutical sciences 1998;87(2):231-7.
-
1998: Heeremans J L; Prevost R; Feitsma H; Kluft C; Crommelin D J
Clot accumulation characteristics of plasminogen-bearing liposomes in a flow-system. Groningen Utrecht Institute for Drug Exploration.
Thrombosis and haemostasis 1998;79(1):144-9.
-
1997: Cherng J Y; van de Wetering P; Talsma H; Crommelin D J; Hennink W E
Freeze-drying of poly((2-dimethylamino)ethyl methacrylate)-based gene delivery systems.
Pharmaceutical research 1997;14(12):1838-41.
-
1997: Zhang W; van Winden E C; Bouwstra J A; Crommelin D J
Enhanced permeability of freeze-dried liposomal bilayers upon rehydration.
Cryobiology 1997;35(3):277-89.
-
1997: van den Elsen J M; van Unen L M; van Bloois L; Busquets M A; Jiskoot W; Hoogerhout P; Wilting J; Herron J N; Crommelin D J
Thermodynamic analysis of the interaction between a bactericidal antibody and a PorA epitope of Neisseria meningitidis.
Biochemistry 1997;36(41):12583-91.
-
1997: van Winden E C; Zhang W; Crommelin D J
Effect of freezing rate on the stability of liposomes during freeze-drying and rehydration.
Pharmaceutical research 1997;14(9):1151-60.
-
1997: Oussoren C; Zuidema J; Crommelin D J; Storm G
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose.
Biochimica et biophysica acta 1997;1328(2):261-72.
-
1997: van den Elsen J M; Herron J N; Hoogerhout P; Poolman J T; Boel E; Logtenberg T; Wilting J; Crommelin D J; Kroon J; Gros P
Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: crystal structure of a Fab fragment in complex with a fluorescein-conjugated peptide.
Proteins 1997;29(1):113-25.
-
1997: van den Elsen J M; van Pomeren E; Poolman J T; Wilting J; Herron J N; Crommelin D J
On the interaction between a bactericidal antibody and a PorA epitope of Neisseria meningitidis in outer membrane vesicles: a competitive fluorescence polarization immunoassay.
Analytical biochemistry 1997;247(2):382-8.
-
1997: Storm G; Crommelin D J
Colloidal systems for tumor targeting.
Hybridoma 1997;16(1):119-25.
-
1996: Vingerhoeds M H; Steerenberg P A; Hendriks J J; Crommelin D J; Storm G
Targeted delivery of diphtheria toxin via immunoliposomes: efficient antitumor activity in the presence of inactivating anti-diphtheria toxin antibodies.
FEBS letters 1996;395(2-3):245-50.
-
1996: Vingerhoeds M H; Steerenberg P A; Hendriks J J; Dekker L C; Van Hoesel Q G; Crommelin D J; Storm G
Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo.
British journal of cancer 1996;74(7):1023-9.
-
1996: Oyen W J; Boerman O C; Storm G; van Bloois L; Koenders E B; Crommelin D J; van der Meer J W; Corstens F H
Labelled Stealth liposomes in experimental infection: an alternative to leukocyte scintigraphy?
Nuclear medicine communications 1996;17(9):742-8.
-
1996: Oyen W J; Boerman O C; Storm G; van Bloois L; Koenders E B; Claessens R A; Perenboom R M; Crommelin D J; van der Meer J W; Corstens F H
Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(8):1392-7.
-
1996: Cherng J Y; van de Wetering P; Talsma H; Crommelin D J; Hennink W E
Effect of size and serum proteins on transfection efficiency of poly ((2-dimethylamino)ethyl methacrylate)-plasmid nanoparticles.
Pharmaceutical research 1996;13(7):1038-42.
-
1996: Vingerhoeds M H; Haisma H J; Belliot S O; Smit R H; Crommelin D J; Storm G
Immunoliposomes as enzyme-carriers (immuno-enzymosomes) for antibody-directed enzyme prodrug therapy (ADEPT): optimization of prodrug activating capacity.
Pharmaceutical research 1996;13(4):604-10.
-
1996: Zuidam N J; Versluis C; Vernooy E A; Crommelin D J
Gamma-irradiation of liposomes composed of saturated phospholipids: effect of bilayer composition, size, concentration and absorbed dose on chemical degradation and physical destabilization of liposomes.
Biochimica et biophysica acta 1996;1280(1):135-48.
-
1996: Heeremans J L; Los P; Prevost R; Crommelin D J; Kluft C
Fibrin binding of plasminogen coated liposomes in vitro.
Thrombosis and haemostasis 1996;75(1):134-9.
-
1996: Storm G; Steerenberg P A; Van Borssum Waalkes M; Crommelin D J
Effects of intraperitoneal administration of free and liposome-entrapped doxorubicin on rat peritoneal exudate cell populations.
Journal of drug targeting 1996;4(4):255-64.
-
1995: Zuidam N J; Lee S S; Crommelin D J
Gamma-irradiation of non-frozen, frozen, and freeze-dried liposomes.
Pharmaceutical research 1995;12(11):1761-8.
-
1995: Zuidam N J; Gouw H K; Barenholz Y; Crommelin D J
Physical (in) stability of liposomes upon chemical hydrolysis: the role of lysophospholipids and fatty acids.
Biochimica et biophysica acta 1995;1240(1):101-10.
-
1995: Zuidam N J; Crommelin D J
Chemical hydrolysis of phospholipids.
Journal of pharmaceutical sciences 1995;84(9):1113-9.
-
1995: Boerman O C; Storm G; Oyen W J; van Bloois L; van der Meer J W; Claessens R A; Crommelin D J; Corstens F H
Sterically stabilized liposomes labeled with indium-111 to image focal infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(9):1639-44.
-
1995: Heeremans J L; Prevost R; Bekkers M E; Los P; Emeis J J; Kluft C; Crommelin D J
Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA.
Thrombosis and haemostasis 1995;73(3):488-94.
-
1995: Bloemen P G; Henricks P A; van Bloois L; van den Tweel M C; Bloem A C; Nijkamp F P; Crommelin D J; Storm G
Adhesion molecules: a new target for immunoliposome-mediated drug delivery.
FEBS letters 1995;357(2):140-4.
-
1995: Heeremans J L; Gerritsen H R; Meusen S P; Mijnheer F W; Gangaram Panday R S; Prevost R; Kluft C; Crommelin D J
The preparation of tissue-type Plasminogen Activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage.
Journal of drug targeting 1995;3(4):301-10.
-
1994: de Smidt J H; Grit M; Crommelin D J
Dissolution kinetics of griseofulvin in mixed micellar solutions.
Journal of pharmaceutical sciences 1994;83(9):1209-12.
-
1994: Vingerhoeds M H; Storm G; Crommelin D J
Immunoliposomes in vivo.
ImmunoMethods 1994;4(3):259-72.
-
1994: Bergers J J; Den Otter W; Dullens H F; De Groot J W; Steerenberg P A; Filius P M; Crommelin D J
Effect of immunomodulators on specific tumor immunity induced by liposome-encapsulated tumor-associated antigens.
International journal of cancer. Journal international du cancer 1994;56(5):721-6.
-
1994: Talsma H; van Steenbergen M J; Borchert J C; Crommelin D J
A novel technique for the one-step preparation of liposomes and nonionic surfactant vesicles without the use of organic solvents. Liposome formation in a continuous gas stream: the 'bubble' method.
Journal of pharmaceutical sciences 1994;83(3):276-80.
-
1993: Bergers J J; Den Otter W; Dullens H F; Kerkvliet C T; Crommelin D J
Interleukin-2-containing liposomes: interaction of interleukin-2 with liposomal bilayers and preliminary studies on application in cancer vaccines.
Pharmaceutical research 1993;10(12):1715-21.
-
1993: Vingerhoeds M H; Haisma H J; van Muijen M; van de Rijt R B; Crommelin D J; Storm G
A new application for liposomes in cancer therapy. Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of prodrugs.
FEBS letters 1993;336(3):485-90.
-
1993: Zuidam N J; Lee S S; Crommelin D J
Sterilization of liposomes by heat treatment.
Pharmaceutical research 1993;10(11):1591-6.
-
1993: Bergers J J; Den Otter W; Dullens H F; De Groot J W; Steerenberg P A; Mimpen M W; Crommelin D J
Critical factors for liposome-incorporated tumour-associated antigens to induce protective tumour immunity to SL2 lymphoma cells in mice.
Cancer immunology, immunotherapy : CII 1993;37(4):271-9.
-
1993: Grit M; Crommelin D J
Chemical stability of liposomes: implications for their physical stability.
Chemistry and physics of lipids 1993;64(1-3):3-18.
-
1993: Grit M; Zuidam N J; Underberg W J; Crommelin D J
Hydrolysis of partially saturated egg phosphatidylcholine in aqueous liposome dispersions and the effect of cholesterol incorporation on hydrolysis kinetics.
The Journal of pharmacy and pharmacology 1993;45(6):490-5.
-
1993: Bergers J J; Vingerhoeds M H; van Bloois L; Herron J N; Janssen L H; Fischer M J; Crommelin D J
The role of protein charge in protein-lipid interactions. pH-dependent changes of the electrophoretic mobility of liposomes through adsorption of water-soluble, globular proteins.
Biochemistry 1993;32(17):4641-9.
-
1993: Grit M; Underberg W J; Crommelin D J
Hydrolysis of saturated soybean phosphatidylcholine in aqueous liposome dispersions.
Journal of pharmaceutical sciences 1993;82(4):362-6.
-
1993: Grit M; Crommelin D J
The effect of surface charge on the hydrolysis kinetics of partially hydrogenated egg phosphatidylcholine and egg phosphatidylglycerol in aqueous liposome dispersions.
Biochimica et biophysica acta 1993;1167(1):49-55.
-
1992: Joles J; Willekes-Koolschijn N; Koomans H; Van Tol A; Geelhoed-Mieras T; Crommelin D; Van Bloois L; Krajnc-Franken M; Cohen L; Griffioen M
Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats.
Laboratory animals 1992;26(4):269-80.
-
1992: Kadir F; Eling W M; Abrahams D; Zuidema J; Crommelin D J
Tissue reaction after intramuscular injection of liposomes in mice.
International journal of clinical pharmacology, therapy, and toxicology 1992;30(10):374-82.
-
1992: Heeremans J L; Kraaijenga J J; Los P; Kluft C; Crommelin D J
Development of a procedure for coupling the homing device glu-plasminogen to liposomes.
Biochimica et biophysica acta 1992;1117(3):258-64.
-
1992: Grit M; Crommelin D J
The effect of aging on the physical stability of liposome dispersions.
Chemistry and physics of lipids 1992;62(2):113-22.
-
1992: Talsma H; Gooris G; v Steenbergen M J; Salomons M A; Bouwstra J; Crommelin D J
The influence of the molar ratio of cholesteryl hemisuccinate/dipalmitoylphosphatidylcholine on 'liposome' formation after lipid film hydration.
Chemistry and physics of lipids 1992;62(2):105-12.
-
1992: Jiskoot W; van de Werken G; Martin J M; Green B N; Beuvery E C; Crommelin D J
Application of electrospray mass spectrometry (ES-MS) for the analysis of monoclonal antibody Fc subunits.
Pharmaceutical research 1992;9(7):945-51.
-
1992: Talsma H; Van Steenbergen M J; Crommelin D J
The cryopreservation of liposomes. 2. Effect of particle size on crystallization behavior and marker retention.
Cryobiology 1992;29(1):80-6.
-
1992: Ressing M E; Jiskoot W; Talsma H; van Ingen C W; Beuvery E C; Crommelin D J
The influence of sucrose, dextran, and hydroxypropyl-beta-cyclodextrin as lyoprotectants for a freeze-dried mouse IgG2a monoclonal antibody (MN12).
Pharmaceutical research 1992;9(2):266-70.
-
1992: Bergers J J; Den Otter W; De Groot J W; De Blois A W; Dullens H F; Steerenberg P A; Crommelin D J
Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cells.
Cancer immunology, immunotherapy : CII 1992;34(4):233-40.
-
1991: Jiskoot W; Bloemendal M; van Haeringen B; van Grondelle R; Beuvery E C; Herron J N; Crommelin D J
Non-random conformation of a mouse IgG2a monoclonal antibody at low pH.
European journal of biochemistry / FEBS 1991;201(1):223-32.
-
1991: Talsma H; van Steenbergen M J; Salemink P J; Crommelin D J
The cryopreservation of liposomes. 1. A differential scanning calorimetry study of the thermal behavior of a liposome dispersion containing mannitol during freezing/thawing.
Pharmaceutical research 1991;8(8):1021-6.
-
1991: Jiskoot W; Hoogerhout P; Beuvery E C; Herron J N; Crommelin D J
Preparation and application of a fluorescein-labeled peptide for determining the affinity constant of a monoclonal antibody-hapten complex by fluorescence polarization.
Analytical biochemistry 1991;196(2):421-6.
-
1991: Poelma F G; Breäs R; Tukker J J; Crommelin D J
Intestinal absorption of drugs. The influence of mixed micelles on on the disappearance kinetics of drugs from the small intestine of the rat.
The Journal of pharmacy and pharmacology 1991;43(5):317-24.
-
1991: Jiskoot W; Van Hertrooij J J; Hoven A M; Klein Gebbinck J W; Van der Velden-de Groot T; Crommelin D J; Beuvery E C
Preparation of clinical grade monoclonal antibodies from serum-containing cell culture supernatants.
Journal of immunological methods 1991;138(2):273-83.
-
1991: de Smidt J H; Offringa J C; Crommelin D J
Dissolution rate of griseofulvin in bile salt solutions.
Journal of pharmaceutical sciences 1991;80(4):399-401.
-
1991: Jiskoot W; Hoven A M; De Koning A A; Leerling M F; Reubsaet C H; Crommelin D J; Beuvery E C
Purification and stabilisation of a poorly soluble mouse IgG3 monoclonal antibody.
Journal of immunological methods 1991;138(2):181-9.
-
1991: Kersten G F; Spiekstra A; Beuvery E C; Crommelin D J
On the structure of immune-stimulating saponin-lipid complexes (iscoms).
Biochimica et biophysica acta 1991;1062(2):165-71.
-
1990: Jiskoot W; Beuvery E C; de Koning A A; Herron J N; Crommelin D J
Analytical approaches to the study of monoclonal antibody stability.
Pharmaceutical research 1990;7(12):1234-41.
-
1990: Titulaer H A; Eling W M; Crommelin D J; Peeters P A; Zuidema J
The parenteral controlled release of liposome encapsulated chloroquine in mice.
The Journal of pharmacy and pharmacology 1990;42(8):529-32.
-
1990: Jiskoot W; Gebbinck J W; van Hertrooij J J; van der Velden-de Groot T; Crommelin D J; Beuvery E C
A purification strategy for the production of clinical grade monoclonal antibodies.
Developments in biological standardization 1990;71():73-8.
-
1989: Jiskoot W; Van Hertrooij J J; Klein Gebbinck J W; Van der Velden-de Groot T; Crommelin D J; Beuvery E C
Two-step purification of a murine monoclonal antibody intended for therapeutic application in man. Optimisation of purification conditions and scaling up.
Journal of immunological methods 1989;124(1):143-56.
-
1989: Peeters P A; de Leest K; Eling W M; Crommelin D J
Chloroquine blood levels after administration of the liposome-encapsulated drug in relation to therapy of murine malaria.
Pharmaceutical research 1989;6(9):787-93.
-
1989: Peeters P A; Huiskamp C W; Eling W M; Crommelin D J
Chloroquine containing liposomes in the chemotherapy of murine malaria.
Parasitology 1989;98 Pt 3():381-6.
-
1989: Peeters P A; Brunink B G; Eling W M; Crommelin D J
Therapeutic effect of chloroquine(CQ)-containing immunoliposomes in rats infected with Plasmodium berghei parasitized mouse red blood cells: comparison with combinations of antibodies and CQ or liposomal CQ.
Biochimica et biophysica acta 1989;981(2):269-76.
-
1989: Poelma F G; Tukker J J; Crommelin D J
Intestinal absorption of drugs. I: The influence of taurocholate on the absorption of dantrolene in the small intestine of the rat.
Journal of pharmaceutical sciences 1989;78(4):285-9.
-
1988: Storm G; Steerenberg P A; van Borssum Waalkes M; Emmen F; Crommelin D J
Potential pitfalls in in vitro antitumor activity testing of free and liposome-entrapped doxorubicin.
Journal of pharmaceutical sciences 1988;77(10):823-30.
-
1988: Peeters P A; Oussoren C; Eling W M; Crommelin D J
Immunospecific targeting of immunoliposomes, F(ab')2 and IgG to red blood cells in vivo.
Biochimica et biophysica acta 1988;943(2):137-47.
-
1988: Kersten G F; van de Put A M; Teerlink T; Beuvery E C; Crommelin D J
Immunogenicity of liposomes and iscoms containing the major outer membrane protein of Neisseria gonorrhoeae: influence of protein content and liposomal bilayer composition.
Infection and immunity 1988;56(6):1661-4.
-
1988: Storm G; Steerenberg P A; Emmen F; van Borssum Waalkes M; Crommelin D J
Release of doxorubicin from peritoneal macrophages exposed in vivo to doxorubicin-containing liposomes.
Biochimica et biophysica acta 1988;965(2-3):136-45.
-
1988: Kersten G F; Teerlink T; Derks H J; Verkleij A J; van Wezel T L; Crommelin D J; Beuvery E C
Incorporation of the major outer membrane protein of Neisseria gonorrhoeae in saponin-lipid complexes (iscoms): chemical analysis, some structural features, and comparison of their immunogenicity with three other antigen delivery systems.
Infection and immunity 1988;56(2):432-8.
-
1987: Offringa J C; Plekkenpol R; Crommelin D J
A differential scanning calorimetry study of the thermal behavior of water-dipalmitoylphosphatidylcholine mixtures at subzero temperatures: effects of water content, surface charge, and cholesterol.
Journal of pharmaceutical sciences 1987;76(10):821-4.
-
1987: de Smidt J H; Offringa J C; Crommelin D J
Dissolution kinetics of griseofulvin in sodium dodecylsulphate solutions.
Journal of pharmaceutical sciences 1987;76(9):711-4.
-
1986: Jiskoot W; Teerlink T; Van Hoof M M; Bartels K; Kanhai V; Crommelin D J; Beuvery E C
Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes.
Infection and immunity 1986;54(2):333-8.
-
1986: de Smidt J H; Fokkens J G; Grijseels H; Crommelin D J
Dissolution of theophylline monohydrate and anhydrous theophylline in buffer solutions.
Journal of pharmaceutical sciences 1986;75(5):497-501.
-
1985: Storm G; van Bloois L; Brouwer M; Crommelin D J
The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation.
Biochimica et biophysica acta 1985;818(3):343-51.
-
1984: Grijseels H; Crommelin D J; De Blaey C J
Dissolution at porous interfaces VI: Multiple pore systems.
Journal of pharmaceutical sciences 1984;73(12):1771-4.
Sign-in to see more
